FindTrial
Sign In

The study of clinical and predictive value of Peripheral Artery Volume (PAV) to assess endothelial function in patients with coronary artery disease

The study of clinical and predictive value of Peripheral Artery Volume (PAV) to assess endothelial function in patients with coronary artery disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17011214
Enrollment
Unknown
Registered
2017-04-22
Start date
2017-05-10
Completion date
Unknown
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

Gold Standard:Coronary angiography will be used as gold standard of diagnostic measures of coronary artery disease
Index test:Peripheral&#32
arterial&#32
volume&#32
(PAV)&#32
detected&#32
by&#32
an&#32
oximeter-like&#32
probe&#32

Sponsors

China-Japan Union Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients were eligible for enrollment if they had stable angina pectoris by history taking, were scheduled to undergo coronary angiography (CAG), and were aged between 30 to 75 years

Exclusion criteria

Exclusion criteria: Exclusion criteria included acute coronary syndrome; left ventricular ejection <55%; Raynauds disease; atrial fibrillation; valvular heart disease; chronic respiratory, endocrine or renal disease

Design outcomes

Primary

MeasureTime frame
Peripheral Artery Volume (PAV);—

Countries

China

Contacts

Public ContactPing Yang

China-Japan Union Hospital of Jilin University

pyang@jlu.edu.cn+86 043184995091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026